ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2023
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Markets News

Don’t miss $10 bn diagnostics industry! Metropolis Healthcare, Dr Lal PathLabs & Vijaya Diagnostics top buys

The USD10bn diagnostics market in India has been growing at a healthy 12-14% CAGR, with growth being largely volume-driven, and there is plenty of opportunities for companies to grow even from current levels, Centrum Broking said in a note.  

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Don’t miss $10 bn diagnostics industry! Metropolis Healthcare, Dr Lal PathLabs & Vijaya Diagnostics top buys
Representational Image. Source: Reuters

The USD10bn diagnostics market in India has been growing at a healthy 12-14% CAGR, with growth being largely volume-driven, and there is plenty of opportunities for companies to grow even from current levels, Centrum Broking said in a note.

See Zee Business Live TV Streaming Below:

The domestic brokerage firm believes there is a massive opportunity, the industry offers, and consolidation would help sustain the high growth momentum for organised chains.

Centrum initiates coverage with a buy recommendation on Metropolis Healthcare with a target of Rs 3999, Dr Lal PathLabs with a target of Rs 4,999, and Vijaya Diagnostics with a target of Rs 699.

The brokerage firm anticipates a faster shift to organized providers, given the quality set-up, faster report turnaround, complex test availability, and better customer experience they offer.

With their pan India network, organized players also benefit from economies of scale and are able to provide better illness management for patients and better diagnosis for doctors.

The wellness approach towards health is still at a nascent stage in India while the pandemic has added a major push to wellness and overall healthcare penetration in India.

Indian Healthcare Market:

India’s healthcare industry has recorded a CAGR of around 22% since CY16, according to Niti Aayog. At this rate, it is expected to reach USD372bn in CY22.

The healthcare delivery market (hospitals), which was valued at approximately Rs4,400bn, is projected to grow at a CAGR of 17-18% over FY21-25.

The pharmaceuticals industry, of which the domestic formulations segment was valued at approximately Rs1,420bn, is projected to grow at a CAGR of 11-12% over FY21-25.

The diagnostics industry, which was valued at Rs710-730bn, is projected to grow at a CAGR of 14-16% over FY21-23.

Covid Boost!

The pandemic has forced the government to focus on healthcare. Increasing awareness and reach should drive higher growth and penetration for the healthcare sector in India.

Centrum believes that the pandemic has left patients with continuous follow up and monitoring of wellness post infection, driving demand.

Pandemic has also brought the importance of quality and reliability of clinical data driving the demand to organised players. “We expect this to enhance and boost the positioning of organised players,” said the note.

Ample room for growth:

The pan-India chains have 6 per cent market share in the USD10bn diagnostics industry in India. Metropolis’ patient reach is half of DLPL’s, highlighting the different models followed in the sector.

Growth has been volume-driven, which drives significant earnings visibility with further upsides from consolidation, shift to wellness from illness, aging population, and specialized testing with focus on B2C share.

“We believe there is a strong investment case for diagnostics as a structural opportunity. The leading players have delivered stellar return ratios upwards of 30% and commendable cash flow generations with FCF/PAT been ahead of 100%,” said the note.

The lower capex intensity and a plug-play model ensures strong volume growth visibility over time.

(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Indian healthcare market
Written By: Kshitij Anand
Updated: Thu, Dec 02, 2021
11:26 am
New Delhi , ZeeBiz WebDesk
RELATED NEWS
Indian healthcare may grow threefold to $372 billion by 2022: Assocham Indian healthcare may grow threefold to $372 billion by 2022: Assocham

LATEST NEWS

JBM Group to foray into electric bus markets of THESE 6 states - check list here

Kiara Advani and Sidharth Malhotra wedding: Bride-to-be arrives at marriage venue in Jaisalmer

ITC Dividend 2023: Check record date, ex-date and payment date | ITC Share Price NSE Target

Pathaan Box Office Collection: Shah Rukh Khan-starrer raises Rs 729 crore worldwide - Check domestic collection after Day 10| OTT release date here

Gold Price Today (February 4): Yellow metal dips over Rs 2,500 from record high - Check rate in Delhi, Mumbai and other cities

Pakistan's rupee continues speedy crash against US dollar, suffers another big fall

Lupin's subsidiary recalls over 5,500 skin treatment ointments from US amid manufacturing issue

UGC NET 2023: UGC-National Eligibility Test Admit card to be released soon — Check exam date, how to download admit card, other details here

Q3 Results 2023: Paytm narrows loss, IndiGo's net profit soars to Rs 1,422.6 crore

Ajit Kumar starrer Thunivu OTT release date Announced! Check when and where to watch

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. India Dot Com Private Limited. All Rights Reserved.
LIVE TV